Status: Recruiting
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
This trial aims to demonstrate the feasibility of this approach to reliably generate product and to safely administer the product to patients who have B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia.
Participants needed: 30
Trial details
Phase: Phase 2Age: 18-79Biological sex: AllType: InterventionalSponsor: John ListerUpdated: Jan 13, 2025Locations: 1
Eligibility criteria
Subjects with CD19+ B-cell lymphoma or B-Cell Acute Lymphoblastic Leukemia (B-AL... [+17]
Infection with HIV (human immunodeficiency virus) and active viral replication.... [+15]